helpline 01494 601 400

Clare Pelham

Our CEO says "wow" to latest discoveries in epilepsy

In her New Year blog, our chief executive, Clare Pelham, shares her excitement at learning of the latest scientific discoveries in the field of epilepsy from researchers at Epilepsy Society.

Epilepsy Society visits Parliament to discuss service review for epilepsy

Epilepsy Society visits Parliament

Epilepsy Society's Chief Executive Clare Pelham joined SUDEP Action and The Daisy Garland charity in Parliament this week to discuss service review for epilepsy and the research and implications of Brexit.

Clare Pelham comments on new sodium valproate regulations

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.

Charity tells health secretary new drug regulations could fail without public campaign

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.

Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'

Consultation launched on whether tax treatment of charities needs reform

Logo for the NCVO which is white lettering on a purple background

The Charity Tax Commission has launched a consultation seeking views on whether and how the tax treatment of charities - estimated to be worth around £3.7bn a year - needs to be reformed.

EMA publishes recommendations on sodium valproate

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).

Clare Pelham joins expert group on sodium valproate

Chief executive Clare Pelham is wearing a purple top and resting her chin pensively on her hand.

Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.

2017 ended with a disaster but we're not beaten

Epilepsy Society's chief executive Clare Pelham looks back over the year, at the highs and - sadly - a very snowy low.

How you helped our sodium valproate campaign by filling in our survey

Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.

Pages

Subscribe to RSS - Clare Pelham